Results 201 to 210 of about 396,315 (223)

Castigo y sociedad moderna.

2021
openaire   +1 more source

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Morbidity and Mortality Weekly Report, 2021
Wesley H Self, Manjusha Gaglani, Nicholas M Mohr   +2 more
exaly  

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database

Vaccines, 2021
Mansour Tobaiqy, Katie MacLure, Hajer Elkout   +2 more
exaly  

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Nature Medicine, 2022
Julia Stowe, Freja C M Kirsebom, James A Lopez Bernal   +2 more
exaly  

Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report

Journal of Infection and Public Health, 2021
Joyce Kong, Francisco Cuevas, Mahmoud Nassar,,,, Mha, Mpa, Cphq, Ssbb   +2 more
exaly  

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020

Morbidity and Mortality Weekly Report, 2021
Megan Wallace
exaly  

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Morbidity and Mortality Weekly Report, 2021
Wesley H Self, Ithan D Peltan, Akram Khan   +2 more
exaly  

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Nature, 2021
Alice Cho, Frauke Mücksch, Dennis J Schaefer-Babajew   +2 more
exaly  

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021

Morbidity and Mortality Weekly Report, 2021
Nicholas M Mohr, David A Talan, Karisa K Harland   +2 more
exaly  

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccine in Patients with Hypersensitivity to First Dose

Open Forum Infectious Diseases, 2021
Peter Capucilli, Allison Ramsey, Edward E Walsh   +2 more
exaly